1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
- 1 July 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9124) , 314-316
- https://doi.org/10.1016/s0140-6736(98)04084-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998
- Antiretroviral Therapy for HIV InfectionDrugs, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- British HIV Association guidelines for antiretroviral treatment of HIV seropositive individualsThe Lancet, 1997
- To sequence or not to sequence?Expert Opinion on Investigational Drugs, 1997
- Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing complianceAIDS Care, 1996
- Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 1995